Critical Considerations about Clinical Trials Simulation

ISSN： 1364-9027

Source： International Journal of Pharmaceutical Medicine, Vol.20, Iss.1, 2006-01, pp. : 1-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ethical Considerations in Clinical Trials

Heart Drug, Vol. 1, Iss. 1, 2001-03 ,pp. : 2-4

Karger

Access to resources Recommend Favorite

Clinical Trials Simulation: A Statistical Approach

By Westfall Peter

Journal of Biopharmaceutical Statistics, Vol. 18, Iss. 4, 2008-07 ,pp. : 611-630

Taylor & Francis Ltd

Access to resources Recommend Favorite

Internet-Based Clinical Trials: Practical Considerations

By Mitchel J.T.

Pharmaceutical Development and Regulation, Vol. 1, Iss. 1, 2003-01 ,pp. : 29-39

Adis International

Access to resources Recommend Favorite

Statistical Considerations for Testing Multiple Endpoints in Group Sequential or Adaptive Clinical Trials

By Hung H. M. James

Journal of Biopharmaceutical Statistics, Vol. 17, Iss. 6, 2007-11 ,pp. : 1201-1210

Taylor & Francis Ltd

Access to resources Recommend Favorite

Recommendations for the Treatment of Hypertension in Patients with DM: Critical Evaluation Based on Clinical Trials

Current Clinical Pharmacology, Vol. 1, Iss. 1, 2006-01 ,pp. : 21-33

Bentham Science Publishers

Access to resources Recommend Favorite